Variation in Single Gene May Determine Response to Humira in IBD Patients, Study Reports

Variation in Single Gene May Determine Response to Humira in IBD Patients, Study Reports
A single variation in the DNA sequence of a particular gene, called ATG16L1, was associated with response to Humira (adalimumab) treatment in a group of people with inflammatory bowel disease (IBD), a disease in which genetics is known to play a role and newer therapies have had a somewhat mixed response. Humira, with Remicade (infliximab), is

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *